Ever Supreme Bio Technology Co. Ltd. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was TWD 91.048 million compared to TWD 9.619 million a year ago. Operating income was TWD 20.007 million compared to operating loss of TWD 47.674 million a year ago. Net income was TWD 67.688 million compared to net loss of TWD 41.074 million a year ago. Basic earnings per share from continuing operations was TWD 1.1 compared to basic loss per share from continuing operations of TWD 0.73 a year ago. Diluted earnings per share from continuing operations was TWD 1.09 compared to diluted loss per share from continuing operations of TWD 0.73 a year ago. For the half year, sales was TWD 140.040 million compared to TWD 17.381 million a year ago. Operating income was TWD 5.941 million compared to operating loss of TWD 81.313 million a year ago. Net income was TWD 54.247 million compared to net loss of TWD 67.135 million a year ago. Basic earnings per share from continuing operations was TWD 0.88 compared to basic loss per share from continuing operations of TWD 1.2 a year ago. Diluted earnings per share from continuing operations was TWD 0.87 compared to diluted loss per share from continuing operations of TWD 1.2 a year ago.